loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for cep_2019_005___rev_04 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Linde

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    PharmaCompass

    Inke S.A: APIs manufacturing plant.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 LINDE GMBH Pullach DE (1)

    filter

    01 Oxygen (1)

    filter

    01 U.S.A (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    LINDE GMBH Pullach DE

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag U.S.A
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Oxygen

      PDF Supplier PDF
      URL Supplier Web Content
      CEP 2019-005 - Rev 04
      Valid
      Chemical
      2024-02-09
      417
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for Certificates of Suitability (CEPs) for CEP 2019-005 - Rev 04 of Linde Gmbh Pullach De

      Looking for Certificates of Suitability (CEPs) for CEP 2019-005 - Rev 04 of Linde Gmbh Pullach De 1

      20

      Linde Gmbh Pullach De, based in U.S.A, is a pharmaceutical company.

      One of their significant offerings is Oxygen, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2019-005 - Rev 04

      This Chemical Type CEP, issued on February 09, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

      Substance Number 417 associated with this CEP further emphasizes

      Post Enquiry
      POST ENQUIRY